Gene therapy for metastatic melanoma in mice produces complete remission

November 19, 2010

INDIANAPOLIS - A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in the December 2010 issue of the Journal of Clinical Investigation. The online version is now available.

Indiana University School of Medicine researchers used a modified lentivirus to introduce a potent anti-melanoma T cell receptor gene into the hematopoietic stem cells of mice. Hematopoietic stem cells are the bone marrow cells that produce all blood and immune system cells.

The T cell gene, which recognizes a specific protein found on the surface of melanoma, was isolated and cloned from a patient with melanoma. The gene-modified stems cells were then transplanted back into hosts and found to eradicate metastatic melanoma for the lifetime of the mice.

"We found that the transplantation of gene-modified hematopoietic stem cells results in a new host immune system and the complete elimination of tumor," reported Christopher E. Touloukian, M.D., an assistant professor of surgery and immunology at the IU School of Medicine and a member of the Indiana University Melvin and Bren Simon Cancer Center. "To date, cancer immunotherapies have been hampered by limited and diminishing immune responses over time. We believe this type of translational model opens new doors for patients with melanoma and potentially other cancers by taking advantage of the potent regenerative capacity of hematopoietic stem cells and new advances in gene therapy."

This research was funded by a National Institutes of Health grant.

It has paved the way for a new clinical trial in humans funded by the V Foundation for Cancer Research. The pilot phase I trial will involve treatment of 12 patients and focus primarily on the safety and efficacy of the therapy, said Dr. Touloukian, who is the senior author on the JCI paper and the principal investigator for the clinical study. The clinical trial is expected to begin accruing patients by late 2011.

In 2010, more than 68,000 patients will be diagnosed with melanoma and the disease will be associated with approximately 9,000 deaths. The state of Indiana has the 11th highest rate of melanoma incidence of all 50 states. Current treatments for metastatic melanoma, though exciting and innovative, have been highly toxic and largely unsuccessful with the most patients dying within 6 to 12 months after diagnosis.

Indiana University School of Medicine

---

---

	Metastatic Melanoma: Symptoms, Diagnoses, and Treatments (Cancer Etiology, Diagnosis and Treatments) by Sarah A. Klein (Other Contributor) Melanomas are usually highly proliferative, invasive and are most frequently metastatic. Melanoma accounts for nearly 4 per cent of skin cancer cases but, because of its highly metastatic capability, for 74 per cent of all skin cancer mortalities. Therefore, melanoma is one of the deadliest forms of cancer and its treatment continues to be challenging. This book presents topical research in the study of the symptoms, diagnoses and treatment of metastatic melanoma. Topics discussed include new therapeutic alternatives for melanoma; the metastatic cascade and experimental treatments; pediatric melanoma; and, the relative risk of metastatic melanoma.
	Peptide vaccine for metastatic melanoma shows promise: immune response in 38%.(News): An article from: Skin & Allergy News by Damian McNamara (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on February 1, 2004. The length of the article is 1537 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Peptide vaccine for metastatic melanoma shows promise: immune response in 38%.(News) Author: Damian McNamara Publication: Skin & Allergy News (Magazine/Journal) Date: February 1, 2004 Publisher: International Medical News Group Volume: 35 Issue: 2 Page: 7(1) Distributed by Thomson...
	Combo Tx may help fight metastatic melanoma: add antisense therapy.(Dermatologic Therapy): An article from: Skin & Allergy News by Damian McNamara (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on February 1, 2004. The length of the article is 555 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Combo Tx may help fight metastatic melanoma: add antisense therapy.(Dermatologic Therapy) Author: Damian McNamara Publication: Skin & Allergy News (Magazine/Journal) Date: February 1, 2004 Publisher: International Medical News Group Volume: 35 Issue: 2 Page: 30(1) Distributed by Thomson...
	Insights into mutations may revolutionize Metastatic melanoma Tx. (Targeted Therapy).: An article from: Skin & Allergy News by Bruce Jancin (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on May 1, 2003. The length of the article is 653 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Insights into mutations may revolutionize Metastatic melanoma Tx. (Targeted Therapy). Author: Bruce Jancin Publication: Skin & Allergy News (Magazine/Journal) Date: May 1, 2003 Publisher: International Medical News Group Volume: 34 Issue: 5 Page: 16(1) Distributed by Thomson...
	Melanoma Vaccine Doubles Survival in Metastatic Disease.: An article from: Skin & Allergy News by Timothy F. Kirn (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on July 1, 2001. The length of the article is 774 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Melanoma Vaccine Doubles Survival in Metastatic Disease. Author: Timothy F. Kirn Publication: Skin & Allergy News (Magazine/Journal) Date: July 1, 2001 Publisher: International Medical News Group Volume: 32 Issue: 7 Page: 21 Distributed by Thomson...
	Metastatic melanoma responds to gene-based Tx.(Rx): An article from: Internal Medicine News by Patrice G.W. Norton (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on October 1, 2004. The length of the article is 605 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Metastatic melanoma responds to gene-based Tx.(Rx) Author: Patrice G.W. Norton Publication: Internal Medicine News (Magazine/Journal) Date: October 1, 2004 Publisher: International Medical News Group Volume: 37 Issue: 19 Page: 54(1) Distributed by Thomson...
	Surgery gaining as metastatic melanoma option.(Clinical Rounds): An article from: Skin & Allergy News by Nancy Walsh (Author) This digital document is an article from Skin & Allergy News, published by Thomson Gale on November 1, 2006. The length of the article is 672 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Surgery gaining as metastatic melanoma option.(Clinical Rounds) Author: Nancy Walsh Publication: Skin & Allergy News (Magazine/Journal) Date: November 1, 2006 Publisher: Thomson Gale Volume: 37 Issue: 11 Page: 30(1) Distributed by Thomson...
	Metastatic Melanoma: resection boosts survival.(Clinical Rounds): An article from: Skin & Allergy News by Mitchel L. Zoler (Author) This digital document is an article from Skin & Allergy News, published by Thomson Gale on August 1, 2006. The length of the article is 701 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Metastatic Melanoma: resection boosts survival.(Clinical Rounds) Author: Mitchel L. Zoler Publication: Skin & Allergy News (Magazine/Journal) Date: August 1, 2006 Publisher: Thomson Gale Volume: 37 Issue: 8 Page: 17(1) Distributed by Thomson...
	Melanoma vaccine fails to curb metastatic disease: allogeneic vaccine shows no advantage over placebo, but overall survival was higher than in earlier ... An article from: Skin & Allergy News by Bruce K. Dixon (Author) This digital document is an article from Skin & Allergy News, published by Thomson Gale on August 1, 2007. The length of the article is 1064 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Melanoma vaccine fails to curb metastatic disease: allogeneic vaccine shows no advantage over placebo, but overall survival was higher than in earlier trials.(News) Author: Bruce K. Dixon Publication: Skin & Allergy News (Magazine/Journal) Date: August 1, 2007 Publisher: Thomson Gale Volume: 38 Issue: 8 Page: 8(1) Distributed by Thomson...
	Treatment of locally metastatic melanoma: a novel approach.(CASE REPORTS)(Case study): An article from: Journal of Drugs in Dermatology by Galina Shistik (Author), Amy V. Prakash (Author), Neil A. Fenske (Author), L. Frank Glass (Author) This digital document is an article from Journal of Drugs in Dermatology, published by Thomson Gale on August 1, 2007. The length of the article is 1523 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Treatment of locally metastatic melanoma: a novel approach.(CASE REPORTS)(Case study) Author: Galina Shistik Publication: Journal of Drugs in Dermatology (Magazine/Journal) Date: August 1, 2007 Publisher: Thomson Gale Volume: 6 Issue: 8 Page: 830(3) Article Type: Case study Distributed by Thomson...